This HSK 7 Mandarin dialogue between Hannah and Samuel covers the FDA's October 2025 approval of oral semaglutide — the first and only oral GLP-1 tablet cleared to reduce cardiovascular risk. You'll hear them discuss how this shifts heart protection away from injections and toward a pill, along with the clinical data behind it.
The conversation runs 18 lines between two speakers. It opens with Samuel sharing that the pharmaceutical world has new approval news, and the exchange builds through questions about clinical trials and specific dosage information.
Key vocabulary includes 医药界 (yīyàojiè, pharmaceutical world), 口服 (kǒufú, oral), 司美格鲁肽 (sīměigélǔtài, semaglutide), 批准 (pīzhǔn, approved), 心脏 (xīnzàng, heart), 血糖 (xuètáng, blood sugar), 适应症 (shìyìngzhèng, indication), and 毫克 (háokè, mg).
Start by listening to the full dialogue at normal speed, then slow playback to 0.5x or 0.75x to catch unfamiliar terms. Replay individual lines as needed. Once you're comfortable, switch to speaking mode: read each line aloud and get pronunciation feedback from Mei Lin. This listen-shadow-speak cycle is the core of free Chinese listening practice with AI dialogues.
If you want to explore other levels, try another HSK 1 listening dialogue titled "Escaping the Heat" or another HSK 6 listening dialogue titled "History at the Track". You can also create a custom Chinese dialogue on any topic if you want to go deeper into Pharmaceutical Innovation or any other subject.
Listening is free without an account, so you can start right away. Synchronized hanzi, pinyin, and English lines let you follow every sentence even when the vocabulary gets dense.
This dialogue covers the FDA's October 2025 approval of oral semaglutide (Rybelsus) as the first oral GLP-1 tablet for reducing cardiovascular risk. Hannah and Samuel discuss how this approval shifts heart protection from injections to a pill, the 7 mg and 14 mg dosages, and the clinical data behind it.
You'll encounter eight key terms including 医药界 (yīyàojiè, pharmaceutical world), 口服 (kǒufú, oral), 司美格鲁肽 (sīměigélǔtài, semaglutide), 批准 (pīzhǔn, approved), 心脏 (xīnzàng, heart), 血糖 (xuètáng, blood sugar), 适应症 (shìyìngzhèng, indication), and 毫克 (háokè, mg). These words let you discuss drug approvals and cardiovascular treatment in Mandarin.
Yes. You can reduce playback speed to 0.5x or 0.75x and replay individual lines as many times as you need. This is especially helpful at HSK 7, where the vocabulary around heart risk and pharmaceutical regulation gets dense and the sentences run longer.
Switch to speaking mode and read each line aloud. Mei Lin gives pronunciation feedback on your Mandarin. You listen first, shadow the audio, then speak — building confidence with terms like 适应症 (shìyìngzhèng, indication) and 司美格鲁肽 (sīměigélǔtài, semaglutide) before producing them yourself.